Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy

OBJECTIVES: The aim of this study is to identify and validate urine exosomal AMACR (UE-A) as a novel biomarker to improve the detection of prostate cancer (PCa) and clinically significant PCa (Gleason score ≥ 7) at initial prostate biopsy. METHODS: A total of 289 first-catch urine samples after the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Xin, Ji, Jin, Niu, Decao, Yang, Yuchen, Tao, Shuchun, Wan, Lilin, Xu, Bin, Chen, Shuqiu, Wang, Fubo, Chen, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251007/
https://www.ncbi.nlm.nih.gov/pubmed/35795046
http://dx.doi.org/10.3389/fonc.2022.904315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251007/
https://www.ncbi.nlm.nih.gov/pubmed/35795046
http://dx.doi.org/10.3389/fonc.2022.904315

Ejemplares similares